Exploring the prevalence of antidepressant medication discontinuation among pregnant veterans
Abstract US female veterans have higher rates of mental health (MH) disorders compared to US civilian females and, consequently, are at risk for poor MH outcomes during pregnancy. This study evaluated the MH burden and identified the prevalence of antidepressant prescription and discontinuation amon...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Howard, Megan [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2023 |
|---|
| Schlagwörter: |
|---|
| Anmerkung: |
© This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Archives of Women's Mental Health - Springer-Verlag, 2002, 27(2023), 1 vom: 23. Sept., Seite 89-97 |
|---|---|
| Übergeordnetes Werk: |
volume:27 ; year:2023 ; number:1 ; day:23 ; month:09 ; pages:89-97 |
| Links: |
|---|
| DOI / URN: |
10.1007/s00737-023-01372-7 |
|---|
| Katalog-ID: |
SPR054403944 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR054403944 | ||
| 003 | DE-627 | ||
| 005 | 20240117064647.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240117s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00737-023-01372-7 |2 doi | |
| 035 | |a (DE-627)SPR054403944 | ||
| 035 | |a (SPR)s00737-023-01372-7-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Howard, Megan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Exploring the prevalence of antidepressant medication discontinuation among pregnant veterans |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023 | ||
| 520 | |a Abstract US female veterans have higher rates of mental health (MH) disorders compared to US civilian females and, consequently, are at risk for poor MH outcomes during pregnancy. This study evaluated the MH burden and identified the prevalence of antidepressant prescription and discontinuation among pregnant veterans (PGVets). The electronic health records (EHR) of PGVets using the US Veterans Administration’s (VA) maternity care benefits over a two-year period were retrospectively reviewed. Inclusion criteria for this study were a current MH diagnosis of depression, anxiety, or posttraumatic stress disorder (PTSD) at the onset of pregnancy (n=351). Outcomes examined included antidepressant use prior to pregnancy, the use and discontinuation of antidepressants during pregnancy, and risk factors for discontinuation. PGVets had a high MH burden, as indicated by multiple comorbid diagnoses of unipolar depression, anxiety, and PTSD in 67% of the sample. At the onset of pregnancy, 163 (46%) were treated with an antidepressant. Only 56 (34%) continued using antidepressants through the pregnancy. Self-discontinuation (34%) and VA provider discontinuation (31%) of antidepressants were found. Among PGVets with documented past suicidal behaviors, 90% discontinued their active antidepressants. PGVets with indicators for more severe MH diagnoses were most likely to discontinue. The MH burden of PGVets and high rates of antidepressant discontinuation have implications for engaging this population in a higher level of perinatal monitoring and intervention. The findings suggest that VA providers and veterans would benefit from risks and benefits education regarding antidepressant use during pregnancy as well as the provision of alternative therapies. | ||
| 650 | 4 | |a Antidepressant medication |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Veterans |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Perinatal health |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Comorbidities |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Ledoux, Tracey |4 aut | |
| 700 | 1 | |a Llaneza, Danielle |4 aut | |
| 700 | 1 | |a Taylor, Ashley |4 aut | |
| 700 | 1 | |a Sattem, Evan |4 aut | |
| 700 | 1 | |a Menefee, Deleene S. |0 (orcid)0000-0002-9854-561X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Archives of Women's Mental Health |d Springer-Verlag, 2002 |g 27(2023), 1 vom: 23. Sept., Seite 89-97 |w (DE-627)SPR007667299 |7 nnns |
| 773 | 1 | 8 | |g volume:27 |g year:2023 |g number:1 |g day:23 |g month:09 |g pages:89-97 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s00737-023-01372-7 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 951 | |a AR | ||
| 952 | |d 27 |j 2023 |e 1 |b 23 |c 09 |h 89-97 | ||
| author_variant |
m h mh t l tl d l dl a t at e s es d s m ds dsm |
|---|---|
| matchkey_str |
howardmeganledouxtraceyllanezadanielleta:2023----:xlrntervlnefniersateiainicniuto |
| hierarchy_sort_str |
2023 |
| publishDate |
2023 |
| allfields |
10.1007/s00737-023-01372-7 doi (DE-627)SPR054403944 (SPR)s00737-023-01372-7-e DE-627 ger DE-627 rakwb eng Howard, Megan verfasserin aut Exploring the prevalence of antidepressant medication discontinuation among pregnant veterans 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023 Abstract US female veterans have higher rates of mental health (MH) disorders compared to US civilian females and, consequently, are at risk for poor MH outcomes during pregnancy. This study evaluated the MH burden and identified the prevalence of antidepressant prescription and discontinuation among pregnant veterans (PGVets). The electronic health records (EHR) of PGVets using the US Veterans Administration’s (VA) maternity care benefits over a two-year period were retrospectively reviewed. Inclusion criteria for this study were a current MH diagnosis of depression, anxiety, or posttraumatic stress disorder (PTSD) at the onset of pregnancy (n=351). Outcomes examined included antidepressant use prior to pregnancy, the use and discontinuation of antidepressants during pregnancy, and risk factors for discontinuation. PGVets had a high MH burden, as indicated by multiple comorbid diagnoses of unipolar depression, anxiety, and PTSD in 67% of the sample. At the onset of pregnancy, 163 (46%) were treated with an antidepressant. Only 56 (34%) continued using antidepressants through the pregnancy. Self-discontinuation (34%) and VA provider discontinuation (31%) of antidepressants were found. Among PGVets with documented past suicidal behaviors, 90% discontinued their active antidepressants. PGVets with indicators for more severe MH diagnoses were most likely to discontinue. The MH burden of PGVets and high rates of antidepressant discontinuation have implications for engaging this population in a higher level of perinatal monitoring and intervention. The findings suggest that VA providers and veterans would benefit from risks and benefits education regarding antidepressant use during pregnancy as well as the provision of alternative therapies. Antidepressant medication (dpeaa)DE-He213 Veterans (dpeaa)DE-He213 Perinatal health (dpeaa)DE-He213 Comorbidities (dpeaa)DE-He213 Ledoux, Tracey aut Llaneza, Danielle aut Taylor, Ashley aut Sattem, Evan aut Menefee, Deleene S. (orcid)0000-0002-9854-561X aut Enthalten in Archives of Women's Mental Health Springer-Verlag, 2002 27(2023), 1 vom: 23. Sept., Seite 89-97 (DE-627)SPR007667299 nnns volume:27 year:2023 number:1 day:23 month:09 pages:89-97 https://dx.doi.org/10.1007/s00737-023-01372-7 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER AR 27 2023 1 23 09 89-97 |
| spelling |
10.1007/s00737-023-01372-7 doi (DE-627)SPR054403944 (SPR)s00737-023-01372-7-e DE-627 ger DE-627 rakwb eng Howard, Megan verfasserin aut Exploring the prevalence of antidepressant medication discontinuation among pregnant veterans 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023 Abstract US female veterans have higher rates of mental health (MH) disorders compared to US civilian females and, consequently, are at risk for poor MH outcomes during pregnancy. This study evaluated the MH burden and identified the prevalence of antidepressant prescription and discontinuation among pregnant veterans (PGVets). The electronic health records (EHR) of PGVets using the US Veterans Administration’s (VA) maternity care benefits over a two-year period were retrospectively reviewed. Inclusion criteria for this study were a current MH diagnosis of depression, anxiety, or posttraumatic stress disorder (PTSD) at the onset of pregnancy (n=351). Outcomes examined included antidepressant use prior to pregnancy, the use and discontinuation of antidepressants during pregnancy, and risk factors for discontinuation. PGVets had a high MH burden, as indicated by multiple comorbid diagnoses of unipolar depression, anxiety, and PTSD in 67% of the sample. At the onset of pregnancy, 163 (46%) were treated with an antidepressant. Only 56 (34%) continued using antidepressants through the pregnancy. Self-discontinuation (34%) and VA provider discontinuation (31%) of antidepressants were found. Among PGVets with documented past suicidal behaviors, 90% discontinued their active antidepressants. PGVets with indicators for more severe MH diagnoses were most likely to discontinue. The MH burden of PGVets and high rates of antidepressant discontinuation have implications for engaging this population in a higher level of perinatal monitoring and intervention. The findings suggest that VA providers and veterans would benefit from risks and benefits education regarding antidepressant use during pregnancy as well as the provision of alternative therapies. Antidepressant medication (dpeaa)DE-He213 Veterans (dpeaa)DE-He213 Perinatal health (dpeaa)DE-He213 Comorbidities (dpeaa)DE-He213 Ledoux, Tracey aut Llaneza, Danielle aut Taylor, Ashley aut Sattem, Evan aut Menefee, Deleene S. (orcid)0000-0002-9854-561X aut Enthalten in Archives of Women's Mental Health Springer-Verlag, 2002 27(2023), 1 vom: 23. Sept., Seite 89-97 (DE-627)SPR007667299 nnns volume:27 year:2023 number:1 day:23 month:09 pages:89-97 https://dx.doi.org/10.1007/s00737-023-01372-7 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER AR 27 2023 1 23 09 89-97 |
| allfields_unstemmed |
10.1007/s00737-023-01372-7 doi (DE-627)SPR054403944 (SPR)s00737-023-01372-7-e DE-627 ger DE-627 rakwb eng Howard, Megan verfasserin aut Exploring the prevalence of antidepressant medication discontinuation among pregnant veterans 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023 Abstract US female veterans have higher rates of mental health (MH) disorders compared to US civilian females and, consequently, are at risk for poor MH outcomes during pregnancy. This study evaluated the MH burden and identified the prevalence of antidepressant prescription and discontinuation among pregnant veterans (PGVets). The electronic health records (EHR) of PGVets using the US Veterans Administration’s (VA) maternity care benefits over a two-year period were retrospectively reviewed. Inclusion criteria for this study were a current MH diagnosis of depression, anxiety, or posttraumatic stress disorder (PTSD) at the onset of pregnancy (n=351). Outcomes examined included antidepressant use prior to pregnancy, the use and discontinuation of antidepressants during pregnancy, and risk factors for discontinuation. PGVets had a high MH burden, as indicated by multiple comorbid diagnoses of unipolar depression, anxiety, and PTSD in 67% of the sample. At the onset of pregnancy, 163 (46%) were treated with an antidepressant. Only 56 (34%) continued using antidepressants through the pregnancy. Self-discontinuation (34%) and VA provider discontinuation (31%) of antidepressants were found. Among PGVets with documented past suicidal behaviors, 90% discontinued their active antidepressants. PGVets with indicators for more severe MH diagnoses were most likely to discontinue. The MH burden of PGVets and high rates of antidepressant discontinuation have implications for engaging this population in a higher level of perinatal monitoring and intervention. The findings suggest that VA providers and veterans would benefit from risks and benefits education regarding antidepressant use during pregnancy as well as the provision of alternative therapies. Antidepressant medication (dpeaa)DE-He213 Veterans (dpeaa)DE-He213 Perinatal health (dpeaa)DE-He213 Comorbidities (dpeaa)DE-He213 Ledoux, Tracey aut Llaneza, Danielle aut Taylor, Ashley aut Sattem, Evan aut Menefee, Deleene S. (orcid)0000-0002-9854-561X aut Enthalten in Archives of Women's Mental Health Springer-Verlag, 2002 27(2023), 1 vom: 23. Sept., Seite 89-97 (DE-627)SPR007667299 nnns volume:27 year:2023 number:1 day:23 month:09 pages:89-97 https://dx.doi.org/10.1007/s00737-023-01372-7 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER AR 27 2023 1 23 09 89-97 |
| allfieldsGer |
10.1007/s00737-023-01372-7 doi (DE-627)SPR054403944 (SPR)s00737-023-01372-7-e DE-627 ger DE-627 rakwb eng Howard, Megan verfasserin aut Exploring the prevalence of antidepressant medication discontinuation among pregnant veterans 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023 Abstract US female veterans have higher rates of mental health (MH) disorders compared to US civilian females and, consequently, are at risk for poor MH outcomes during pregnancy. This study evaluated the MH burden and identified the prevalence of antidepressant prescription and discontinuation among pregnant veterans (PGVets). The electronic health records (EHR) of PGVets using the US Veterans Administration’s (VA) maternity care benefits over a two-year period were retrospectively reviewed. Inclusion criteria for this study were a current MH diagnosis of depression, anxiety, or posttraumatic stress disorder (PTSD) at the onset of pregnancy (n=351). Outcomes examined included antidepressant use prior to pregnancy, the use and discontinuation of antidepressants during pregnancy, and risk factors for discontinuation. PGVets had a high MH burden, as indicated by multiple comorbid diagnoses of unipolar depression, anxiety, and PTSD in 67% of the sample. At the onset of pregnancy, 163 (46%) were treated with an antidepressant. Only 56 (34%) continued using antidepressants through the pregnancy. Self-discontinuation (34%) and VA provider discontinuation (31%) of antidepressants were found. Among PGVets with documented past suicidal behaviors, 90% discontinued their active antidepressants. PGVets with indicators for more severe MH diagnoses were most likely to discontinue. The MH burden of PGVets and high rates of antidepressant discontinuation have implications for engaging this population in a higher level of perinatal monitoring and intervention. The findings suggest that VA providers and veterans would benefit from risks and benefits education regarding antidepressant use during pregnancy as well as the provision of alternative therapies. Antidepressant medication (dpeaa)DE-He213 Veterans (dpeaa)DE-He213 Perinatal health (dpeaa)DE-He213 Comorbidities (dpeaa)DE-He213 Ledoux, Tracey aut Llaneza, Danielle aut Taylor, Ashley aut Sattem, Evan aut Menefee, Deleene S. (orcid)0000-0002-9854-561X aut Enthalten in Archives of Women's Mental Health Springer-Verlag, 2002 27(2023), 1 vom: 23. Sept., Seite 89-97 (DE-627)SPR007667299 nnns volume:27 year:2023 number:1 day:23 month:09 pages:89-97 https://dx.doi.org/10.1007/s00737-023-01372-7 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER AR 27 2023 1 23 09 89-97 |
| allfieldsSound |
10.1007/s00737-023-01372-7 doi (DE-627)SPR054403944 (SPR)s00737-023-01372-7-e DE-627 ger DE-627 rakwb eng Howard, Megan verfasserin aut Exploring the prevalence of antidepressant medication discontinuation among pregnant veterans 2023 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023 Abstract US female veterans have higher rates of mental health (MH) disorders compared to US civilian females and, consequently, are at risk for poor MH outcomes during pregnancy. This study evaluated the MH burden and identified the prevalence of antidepressant prescription and discontinuation among pregnant veterans (PGVets). The electronic health records (EHR) of PGVets using the US Veterans Administration’s (VA) maternity care benefits over a two-year period were retrospectively reviewed. Inclusion criteria for this study were a current MH diagnosis of depression, anxiety, or posttraumatic stress disorder (PTSD) at the onset of pregnancy (n=351). Outcomes examined included antidepressant use prior to pregnancy, the use and discontinuation of antidepressants during pregnancy, and risk factors for discontinuation. PGVets had a high MH burden, as indicated by multiple comorbid diagnoses of unipolar depression, anxiety, and PTSD in 67% of the sample. At the onset of pregnancy, 163 (46%) were treated with an antidepressant. Only 56 (34%) continued using antidepressants through the pregnancy. Self-discontinuation (34%) and VA provider discontinuation (31%) of antidepressants were found. Among PGVets with documented past suicidal behaviors, 90% discontinued their active antidepressants. PGVets with indicators for more severe MH diagnoses were most likely to discontinue. The MH burden of PGVets and high rates of antidepressant discontinuation have implications for engaging this population in a higher level of perinatal monitoring and intervention. The findings suggest that VA providers and veterans would benefit from risks and benefits education regarding antidepressant use during pregnancy as well as the provision of alternative therapies. Antidepressant medication (dpeaa)DE-He213 Veterans (dpeaa)DE-He213 Perinatal health (dpeaa)DE-He213 Comorbidities (dpeaa)DE-He213 Ledoux, Tracey aut Llaneza, Danielle aut Taylor, Ashley aut Sattem, Evan aut Menefee, Deleene S. (orcid)0000-0002-9854-561X aut Enthalten in Archives of Women's Mental Health Springer-Verlag, 2002 27(2023), 1 vom: 23. Sept., Seite 89-97 (DE-627)SPR007667299 nnns volume:27 year:2023 number:1 day:23 month:09 pages:89-97 https://dx.doi.org/10.1007/s00737-023-01372-7 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER AR 27 2023 1 23 09 89-97 |
| language |
English |
| source |
Enthalten in Archives of Women's Mental Health 27(2023), 1 vom: 23. Sept., Seite 89-97 volume:27 year:2023 number:1 day:23 month:09 pages:89-97 |
| sourceStr |
Enthalten in Archives of Women's Mental Health 27(2023), 1 vom: 23. Sept., Seite 89-97 volume:27 year:2023 number:1 day:23 month:09 pages:89-97 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Antidepressant medication Veterans Perinatal health Comorbidities |
| isfreeaccess_bool |
false |
| container_title |
Archives of Women's Mental Health |
| authorswithroles_txt_mv |
Howard, Megan @@aut@@ Ledoux, Tracey @@aut@@ Llaneza, Danielle @@aut@@ Taylor, Ashley @@aut@@ Sattem, Evan @@aut@@ Menefee, Deleene S. @@aut@@ |
| publishDateDaySort_date |
2023-09-23T00:00:00Z |
| hierarchy_top_id |
SPR007667299 |
| id |
SPR054403944 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">SPR054403944</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240117064647.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">240117s2023 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s00737-023-01372-7</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR054403944</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s00737-023-01372-7-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Howard, Megan</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Exploring the prevalence of antidepressant medication discontinuation among pregnant veterans</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2023</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract US female veterans have higher rates of mental health (MH) disorders compared to US civilian females and, consequently, are at risk for poor MH outcomes during pregnancy. This study evaluated the MH burden and identified the prevalence of antidepressant prescription and discontinuation among pregnant veterans (PGVets). The electronic health records (EHR) of PGVets using the US Veterans Administration’s (VA) maternity care benefits over a two-year period were retrospectively reviewed. Inclusion criteria for this study were a current MH diagnosis of depression, anxiety, or posttraumatic stress disorder (PTSD) at the onset of pregnancy (n=351). Outcomes examined included antidepressant use prior to pregnancy, the use and discontinuation of antidepressants during pregnancy, and risk factors for discontinuation. PGVets had a high MH burden, as indicated by multiple comorbid diagnoses of unipolar depression, anxiety, and PTSD in 67% of the sample. At the onset of pregnancy, 163 (46%) were treated with an antidepressant. Only 56 (34%) continued using antidepressants through the pregnancy. Self-discontinuation (34%) and VA provider discontinuation (31%) of antidepressants were found. Among PGVets with documented past suicidal behaviors, 90% discontinued their active antidepressants. PGVets with indicators for more severe MH diagnoses were most likely to discontinue. The MH burden of PGVets and high rates of antidepressant discontinuation have implications for engaging this population in a higher level of perinatal monitoring and intervention. The findings suggest that VA providers and veterans would benefit from risks and benefits education regarding antidepressant use during pregnancy as well as the provision of alternative therapies.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antidepressant medication</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Veterans</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Perinatal health</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Comorbidities</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ledoux, Tracey</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Llaneza, Danielle</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Taylor, Ashley</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sattem, Evan</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Menefee, Deleene S.</subfield><subfield code="0">(orcid)0000-0002-9854-561X</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Archives of Women's Mental Health</subfield><subfield code="d">Springer-Verlag, 2002</subfield><subfield code="g">27(2023), 1 vom: 23. Sept., Seite 89-97</subfield><subfield code="w">(DE-627)SPR007667299</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:27</subfield><subfield code="g">year:2023</subfield><subfield code="g">number:1</subfield><subfield code="g">day:23</subfield><subfield code="g">month:09</subfield><subfield code="g">pages:89-97</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s00737-023-01372-7</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">27</subfield><subfield code="j">2023</subfield><subfield code="e">1</subfield><subfield code="b">23</subfield><subfield code="c">09</subfield><subfield code="h">89-97</subfield></datafield></record></collection>
|
| author |
Howard, Megan |
| spellingShingle |
Howard, Megan misc Antidepressant medication misc Veterans misc Perinatal health misc Comorbidities Exploring the prevalence of antidepressant medication discontinuation among pregnant veterans |
| authorStr |
Howard, Megan |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)SPR007667299 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut aut aut aut |
| collection |
springer |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
Exploring the prevalence of antidepressant medication discontinuation among pregnant veterans Antidepressant medication (dpeaa)DE-He213 Veterans (dpeaa)DE-He213 Perinatal health (dpeaa)DE-He213 Comorbidities (dpeaa)DE-He213 |
| topic |
misc Antidepressant medication misc Veterans misc Perinatal health misc Comorbidities |
| topic_unstemmed |
misc Antidepressant medication misc Veterans misc Perinatal health misc Comorbidities |
| topic_browse |
misc Antidepressant medication misc Veterans misc Perinatal health misc Comorbidities |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Archives of Women's Mental Health |
| hierarchy_parent_id |
SPR007667299 |
| hierarchy_top_title |
Archives of Women's Mental Health |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)SPR007667299 |
| title |
Exploring the prevalence of antidepressant medication discontinuation among pregnant veterans |
| ctrlnum |
(DE-627)SPR054403944 (SPR)s00737-023-01372-7-e |
| title_full |
Exploring the prevalence of antidepressant medication discontinuation among pregnant veterans |
| author_sort |
Howard, Megan |
| journal |
Archives of Women's Mental Health |
| journalStr |
Archives of Women's Mental Health |
| lang_code |
eng |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
2023 |
| contenttype_str_mv |
txt |
| container_start_page |
89 |
| author_browse |
Howard, Megan Ledoux, Tracey Llaneza, Danielle Taylor, Ashley Sattem, Evan Menefee, Deleene S. |
| container_volume |
27 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Howard, Megan |
| doi_str_mv |
10.1007/s00737-023-01372-7 |
| normlink |
(ORCID)0000-0002-9854-561X |
| normlink_prefix_str_mv |
(orcid)0000-0002-9854-561X |
| title_sort |
exploring the prevalence of antidepressant medication discontinuation among pregnant veterans |
| title_auth |
Exploring the prevalence of antidepressant medication discontinuation among pregnant veterans |
| abstract |
Abstract US female veterans have higher rates of mental health (MH) disorders compared to US civilian females and, consequently, are at risk for poor MH outcomes during pregnancy. This study evaluated the MH burden and identified the prevalence of antidepressant prescription and discontinuation among pregnant veterans (PGVets). The electronic health records (EHR) of PGVets using the US Veterans Administration’s (VA) maternity care benefits over a two-year period were retrospectively reviewed. Inclusion criteria for this study were a current MH diagnosis of depression, anxiety, or posttraumatic stress disorder (PTSD) at the onset of pregnancy (n=351). Outcomes examined included antidepressant use prior to pregnancy, the use and discontinuation of antidepressants during pregnancy, and risk factors for discontinuation. PGVets had a high MH burden, as indicated by multiple comorbid diagnoses of unipolar depression, anxiety, and PTSD in 67% of the sample. At the onset of pregnancy, 163 (46%) were treated with an antidepressant. Only 56 (34%) continued using antidepressants through the pregnancy. Self-discontinuation (34%) and VA provider discontinuation (31%) of antidepressants were found. Among PGVets with documented past suicidal behaviors, 90% discontinued their active antidepressants. PGVets with indicators for more severe MH diagnoses were most likely to discontinue. The MH burden of PGVets and high rates of antidepressant discontinuation have implications for engaging this population in a higher level of perinatal monitoring and intervention. The findings suggest that VA providers and veterans would benefit from risks and benefits education regarding antidepressant use during pregnancy as well as the provision of alternative therapies. © This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023 |
| abstractGer |
Abstract US female veterans have higher rates of mental health (MH) disorders compared to US civilian females and, consequently, are at risk for poor MH outcomes during pregnancy. This study evaluated the MH burden and identified the prevalence of antidepressant prescription and discontinuation among pregnant veterans (PGVets). The electronic health records (EHR) of PGVets using the US Veterans Administration’s (VA) maternity care benefits over a two-year period were retrospectively reviewed. Inclusion criteria for this study were a current MH diagnosis of depression, anxiety, or posttraumatic stress disorder (PTSD) at the onset of pregnancy (n=351). Outcomes examined included antidepressant use prior to pregnancy, the use and discontinuation of antidepressants during pregnancy, and risk factors for discontinuation. PGVets had a high MH burden, as indicated by multiple comorbid diagnoses of unipolar depression, anxiety, and PTSD in 67% of the sample. At the onset of pregnancy, 163 (46%) were treated with an antidepressant. Only 56 (34%) continued using antidepressants through the pregnancy. Self-discontinuation (34%) and VA provider discontinuation (31%) of antidepressants were found. Among PGVets with documented past suicidal behaviors, 90% discontinued their active antidepressants. PGVets with indicators for more severe MH diagnoses were most likely to discontinue. The MH burden of PGVets and high rates of antidepressant discontinuation have implications for engaging this population in a higher level of perinatal monitoring and intervention. The findings suggest that VA providers and veterans would benefit from risks and benefits education regarding antidepressant use during pregnancy as well as the provision of alternative therapies. © This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023 |
| abstract_unstemmed |
Abstract US female veterans have higher rates of mental health (MH) disorders compared to US civilian females and, consequently, are at risk for poor MH outcomes during pregnancy. This study evaluated the MH burden and identified the prevalence of antidepressant prescription and discontinuation among pregnant veterans (PGVets). The electronic health records (EHR) of PGVets using the US Veterans Administration’s (VA) maternity care benefits over a two-year period were retrospectively reviewed. Inclusion criteria for this study were a current MH diagnosis of depression, anxiety, or posttraumatic stress disorder (PTSD) at the onset of pregnancy (n=351). Outcomes examined included antidepressant use prior to pregnancy, the use and discontinuation of antidepressants during pregnancy, and risk factors for discontinuation. PGVets had a high MH burden, as indicated by multiple comorbid diagnoses of unipolar depression, anxiety, and PTSD in 67% of the sample. At the onset of pregnancy, 163 (46%) were treated with an antidepressant. Only 56 (34%) continued using antidepressants through the pregnancy. Self-discontinuation (34%) and VA provider discontinuation (31%) of antidepressants were found. Among PGVets with documented past suicidal behaviors, 90% discontinued their active antidepressants. PGVets with indicators for more severe MH diagnoses were most likely to discontinue. The MH burden of PGVets and high rates of antidepressant discontinuation have implications for engaging this population in a higher level of perinatal monitoring and intervention. The findings suggest that VA providers and veterans would benefit from risks and benefits education regarding antidepressant use during pregnancy as well as the provision of alternative therapies. © This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023 |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER |
| container_issue |
1 |
| title_short |
Exploring the prevalence of antidepressant medication discontinuation among pregnant veterans |
| url |
https://dx.doi.org/10.1007/s00737-023-01372-7 |
| remote_bool |
true |
| author2 |
Ledoux, Tracey Llaneza, Danielle Taylor, Ashley Sattem, Evan Menefee, Deleene S. |
| author2Str |
Ledoux, Tracey Llaneza, Danielle Taylor, Ashley Sattem, Evan Menefee, Deleene S. |
| ppnlink |
SPR007667299 |
| mediatype_str_mv |
c |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| doi_str |
10.1007/s00737-023-01372-7 |
| up_date |
2024-07-04T01:27:14.602Z |
| _version_ |
1803609895971323904 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">SPR054403944</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240117064647.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">240117s2023 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s00737-023-01372-7</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR054403944</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s00737-023-01372-7-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Howard, Megan</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Exploring the prevalence of antidepressant medication discontinuation among pregnant veterans</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2023</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract US female veterans have higher rates of mental health (MH) disorders compared to US civilian females and, consequently, are at risk for poor MH outcomes during pregnancy. This study evaluated the MH burden and identified the prevalence of antidepressant prescription and discontinuation among pregnant veterans (PGVets). The electronic health records (EHR) of PGVets using the US Veterans Administration’s (VA) maternity care benefits over a two-year period were retrospectively reviewed. Inclusion criteria for this study were a current MH diagnosis of depression, anxiety, or posttraumatic stress disorder (PTSD) at the onset of pregnancy (n=351). Outcomes examined included antidepressant use prior to pregnancy, the use and discontinuation of antidepressants during pregnancy, and risk factors for discontinuation. PGVets had a high MH burden, as indicated by multiple comorbid diagnoses of unipolar depression, anxiety, and PTSD in 67% of the sample. At the onset of pregnancy, 163 (46%) were treated with an antidepressant. Only 56 (34%) continued using antidepressants through the pregnancy. Self-discontinuation (34%) and VA provider discontinuation (31%) of antidepressants were found. Among PGVets with documented past suicidal behaviors, 90% discontinued their active antidepressants. PGVets with indicators for more severe MH diagnoses were most likely to discontinue. The MH burden of PGVets and high rates of antidepressant discontinuation have implications for engaging this population in a higher level of perinatal monitoring and intervention. The findings suggest that VA providers and veterans would benefit from risks and benefits education regarding antidepressant use during pregnancy as well as the provision of alternative therapies.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antidepressant medication</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Veterans</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Perinatal health</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Comorbidities</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ledoux, Tracey</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Llaneza, Danielle</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Taylor, Ashley</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sattem, Evan</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Menefee, Deleene S.</subfield><subfield code="0">(orcid)0000-0002-9854-561X</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Archives of Women's Mental Health</subfield><subfield code="d">Springer-Verlag, 2002</subfield><subfield code="g">27(2023), 1 vom: 23. Sept., Seite 89-97</subfield><subfield code="w">(DE-627)SPR007667299</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:27</subfield><subfield code="g">year:2023</subfield><subfield code="g">number:1</subfield><subfield code="g">day:23</subfield><subfield code="g">month:09</subfield><subfield code="g">pages:89-97</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s00737-023-01372-7</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">27</subfield><subfield code="j">2023</subfield><subfield code="e">1</subfield><subfield code="b">23</subfield><subfield code="c">09</subfield><subfield code="h">89-97</subfield></datafield></record></collection>
|
| score |
7.3993683 |